BENDAMUSTINE IN COMBINATION WITH RITUXIMAB AS FIRST LINE THERAPY FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A RETROSPECTIVE REAL PRACTICE ITALIAN MULTICENTRE STUDY

被引：0
|
作者：
Gentile, M. [1 ]
Ciolli, S. [2 ]
Molica, S. [3 ]
Di Renzo, N. [4 ]
Selleri, C. [5 ]
Villa, M. R. [6 ]
De Paolis, M. R. [4 ]
Scortechini, I. [7 ]
Giannotta, A. [8 ]
Minoia, C. [9 ]
Boncompagni, R. [2 ]
Bonanno, V. [10 ]
Levato, L. [3 ]
Musso, M. [10 ]
Mastrullo, L. [6 ]
Melpignano, A. [8 ]
Murru, R. [11 ]
Angelucci, E. [11 ]
Caparrotti, G. [1 ,2 ,12 ]
Guarini, A. [1 ,3 ,13 ]
Pinto, A. [1 ,4 ,14 ]
Ferrara, F. [1 ,5 ,15 ]
Zinzani, P. [1 ,6 ,16 ]
Morabito, F. [1 ,7 ,17 ]
机构：
[1] UOC Ematol Cosenza, Cosenza, Italy
[2] Azienda Osped Univ Careggi, SODC Ematol, Florence, Italy
[3] Pugliese Ciaccio Hosp, Dept Oncol & Haematol, Catanzaro, Italy
[4] Osped Vito Fazzi, Hematol Unit, Lecce, Italy
[5] Univ Salerno, Hematol & SCT Transplant Ctr, Dept Med, AOU San Giovanni Dio & Ruggi Aragona, I-84100 Salerno, Italy
[6] UOC Ematol PO San Gennaro Napoli, Naples, Italy
[7] AO Osped Riuniti Marche, Div Ematol, Ancona, Italy
[8] Osped Antonio Perrino Brindisi, UOC Ematol, Brindisi, Italy
[9] IRCCS Ist Tumori Giovanni Paolo II Bari, UOC Ematol, Bari, Italy
[10] UO Ematol & Trapianto Midollo Osseo La Maddalena, Palermo, Italy
[11] A Businco Cagliari, UO Ematol Osped Oncol, Cagliari, Italy
[12] PO G Moscati Aversa, UO Ematol, Aversa, Italy
[13] IRCCS Ist Tumori Giovanni Paolo II Bari, UOC Ematol, Bari, Italy
[14] IRCCS Fdn G Pascale Napoli, SC Ematol Oncol INT, Naples, Italy
[15] Osped Cardarelli Napoli, Div Ematol, Naples, Italy
[16] L&A Seragnoli Bologna, Inst Hematol & Med Oncol, Bologna, Italy
[17] UOC Ematol Cosenza, Cosenza, Italy
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1503
引用
收藏
页码：584 / 584
页数：1
相关论文
共 50 条
  • [21] Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study
    Iannitto, Emilio
    Morabito, Fortunato
    Mancuso, Salvatrice
    Gentile, Massimo
    Montanini, Antonella
    Augello, Accursio
    Bongarzoni, Velia
    D'Arco, Alfonso
    Di Renzo, Nicola
    Fazzi, Rita
    Franco, Giovanni
    Marasca, Roberto
    Mule, Antonino
    Musso, Maurizio
    Musto, Pellegrino
    Pennese, Elsa
    Piccin, Andrea
    Rota-Scalabrini, Delia
    Visani, Giuseppe
    Rigacci, Luigi
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 (03) : 351 - 357
  • [22] EFFICACY AND SAFETY OF BENDAMUSTINE IN COMBINATION WITH RITUXIMAB FOR ELDERLY PATIENTS WITH PREVIOUSLY UNTREATED B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA. AN ITALIAN RETROSPECTIVE MULTICENTER STUDY
    Laurenti, L.
    Autore, F.
    Innocenti, I.
    Vannata, B.
    Cantonetti, M.
    Del Principe, M. I.
    Mauro, F. R.
    Borza, P. Anticoli
    Bongarzoni, V.
    Ciolli, S.
    Boncompagni, R.
    Sciume, M.
    Vincenti, D.
    Ghio, F.
    Cecconi, N.
    Pitini, V.
    Mondello, P.
    Cariccio, M. R. Lanza
    Gozzetti, A.
    D'Arena, G.
    Murru, R.
    Piccirillo, N.
    Petrini, M.
    Cortelezzi, A.
    Del Poeta, G.
    Foa, R.
    Sica, S.
    HAEMATOLOGICA, 2014, 99 : 324 - 325
  • [23] Bendamustine in chronic lymphocytic leukemia: the future is combination therapy
    Friedberg, Jonathan W.
    LEUKEMIA & LYMPHOMA, 2009, 50 (09) : 1399 - 1400
  • [24] A pilot trial of rituximab and alemtuzumab combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL)
    Nabhan, C
    Patton, D
    Gordon, LI
    Riley, MB
    Kuzel, T
    Tallman, MS
    Rosen, ST
    LEUKEMIA & LYMPHOMA, 2004, 45 (11) : 2269 - 2273
  • [25] Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
    Coutre, Steven E.
    Flinn, Ian W.
    de Vos, Sven
    Barrientos, Jacqueline C.
    Schreeder, Marshall T.
    Wagner-Johnson, Nina D.
    Sharman, Jeff P.
    Boyd, Thomas E.
    Fowler, Nathan
    Dreiling, Lyndah
    Kim, Yeonhee
    Mitra, Siddhartha
    Rai, Kanti
    Leonard, John P.
    Furman, Richard R.
    HEMASPHERE, 2018, 2 (03):
  • [26] Bendamustine plus rituximab in untreated chronic lymphocytic leukemia patients. The MDA-CLL-2015-02 study
    De La Fuente, Adolfo
    Navas, Begona
    Gutierrez, Antonio
    Jose Terol, Maria
    Callejas, Marta
    Garcia Marco, Jose Antonio
    Dolores Garcia-Malo, Maria
    de la Serna, Javier
    Teresa Gonzalez-Gascon y Marin, Isabel
    Sanchis, Laura Garcia
    Ballesteros, Monia
    Benavente, Celina
    Jarque, Isidro
    Ochoa Gullon, Juliana
    Beneit, Paola
    de Ona, Raquel
    Montalabn, Carlos
    Estevez, Monica
    Iglesias, Rebeca
    Diaz-Lopez, Antonio
    Baltasar, Patricia
    LEUKEMIA & LYMPHOMA, 2017, 58 : 200 - 201
  • [27] Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma
    Hainsworth, John D.
    Vazquez, Elizabeth R.
    Spigel, David R.
    Raefsky, Eric
    Bearden, James D.
    Saez, Ruben A.
    Greco, F. Anthony
    CANCER, 2008, 112 (06) : 1288 - 1295
  • [28] Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
    Fischer, Kirsten
    Cramer, Paula
    Busch, Raymonde
    Boettcher, Sebastian
    Bahlo, Jasmin
    Schubert, Joeerg
    Pflueger, Karl H.
    Schott, Silke
    Goede, Valentin
    Isfort, Susanne
    von Tresckow, Julia
    Fink, Anna-Maria
    Buehler, Andreas
    Winkler, Dirk
    Kreuzer, Karl-Anton
    Staib, Peter
    Ritgen, Matthias
    Kneba, Michael
    Doehner, Hartmut
    Eichhorst, Barbara F.
    Hallek, Michael
    Stilgenbauer, Stephan
    Wendtner, Clemens-Martin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3209 - 3216
  • [29] The combination of rituximab and GM-CSF in elderly patients with chronic lymphocytic leukemia (CLL).
    Ferrajoli, A.
    O'Brien, S.
    Faderl, S.
    Wierda, W. G.
    Schlette, E.
    Jorgensen, J. L.
    Reuben, J. M.
    Albitar, M.
    Keating, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 361S - 361S
  • [30] Combination fludarabine, cyclophosphamide and rituximab for previously treated patients with chronic lymphocytic leukemia (CLL).
    Garcia-Manero, G
    O'Brien, S
    Cortes, J
    Giles, F
    Faderl, S
    Lerner, S
    Albitar, M
    Kantarjian, HM
    Keating, MJ
    BLOOD, 2000, 96 (11) : 757A - 757A
12345